Clinical Trial

Prevention of Spontaneous Preterm Birth

Study Description

Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix

The aim of this study is to evaluate the efficacy of cervical cerclage in prevention of spontaneous preterm birth in singleton pregnancies with a short transvaginal cervical length (<=25mm) and without prior spontaneous preterm birth

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Procedure - Cervical cerclage

Transvaginal cervical cerclage placed between 18 0/7 - 23 6/7 weeks

Drug - Vaginal progesterone

Vaginal progesterone 200mg suppository or 90mg gel nightly from randomization until 36 weeks

Additional Information

Official Study Title

Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length: a Randomized Clinical Trial

Clinical Trial ID

NCT03251729

ParticipAid ID

Pe9M3e